CAUSEWAY
  • Home
  • About
    • About Us
    • Our Mission
    • Our Technology
  • Team
    • Leadership
    • Board
    • Advisors
  • Programs
    • Pipeline
    • Tendinopathy
    • Osteoarthritis
    • Intervertebral disc disease
    • Skin Ageing
    • Wound Healing
  • Publications
  • Animal Health
  • News
  • Careers
  • Investors
  • Contact

EquiMiR for Equine superficial digital flexor tendonitis 


Picture
Tendon injury is one of the most common injuries in competing horses and one of the leading causes of retirement in racehorses (1).  Of these, injuries to the superficial digital flexor tendon are by far the most common accounting for 75-93% of cases. 

Recognising the impact of these injuries on both horse and owner, Causeway has developed EquiMiR a novel microRNA therapy that targets key disease pathways active in tendinopathy improving the speed and quality of tendon healing.  

EquiMiR has been tested into two randomised controlled equine trials that showed a single dose delivered by ultrasound-guided injection into damaged tendons resulted in better-healed tendons (2).

[1] Thorpe et al., 2010 Equine veterinary Journal
[2] Watts et al., 2017 Cell Molecular Therapy 
“I have never seen lesions heal as quickly and completely as some horses in this study”.
Dr Ashlee Watts, Director Equine Orthopaedics & Regenerative Medicine lab.
Texas A&M University

Picture
Connect on Social
Causeway Therapeutics
Imaging Centre of Excellence Building
Queen Elizabeth University Hospital
Glasgow, G51 4TF
 
Office  +44 141 451 6824
  • Home
  • About
    • About Us
    • Our Mission
    • Our Technology
  • Team
    • Leadership
    • Board
    • Advisors
  • Programs
    • Pipeline
    • Tendinopathy
    • Osteoarthritis
    • Intervertebral disc disease
    • Skin Ageing
    • Wound Healing
  • Publications
  • Animal Health
  • News
  • Careers
  • Investors
  • Contact